Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Accelagen Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (49)
Prescription medicine registration (20)
Cancellation by sponsor (5)
Prescription medicine evaluation (4)
COVID-19 test kit (1)

Date

2024 (6)
2023 (1)
2022 (29)
2021 (17)
2020 (16)
2019 (4)
2016 (2)
2001 (4)

Results for "[search-keyword]"

Search

Sponsor content

79 result(s) found, displaying 51 to 60

MSN-LURASIDONE lurasidone hydrochloride 40 mg tablet blister pack (317302)

17 March 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-LURASIDONE lurasidone hydrochloride 40 mg tablet blister pack.
MSN-LURASIDONE lurasidone hydrochloride 80 mg tablet blister pack (317303)

17 March 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-LURASIDONE lurasidone hydrochloride 80 mg tablet blister pack.
TALMINEX oseltamivir (as phosphate) 75 mg capsule blister pack (312887)

25 February 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TALMINEX oseltamivir (as phosphate) 75 mg capsule blister pack.
TALMINEX oseltamivir (as phosphate) 30 mg capsule blister pack (312888)

25 February 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TALMINEX oseltamivir (as phosphate) 30 mg capsule blister pack.
TALMINEX oseltamivir (as phosphate) 45 mg capsule blister pack (312889)

25 February 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TALMINEX oseltamivir (as phosphate) 45 mg capsule blister pack.
MSN-SOLIFENACIN solifenacin succinate 5 mg film-coated tablet blister pack (314023)

10 January 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-SOLIFENACIN solifenacin succinate 5 mg film-coated tablet blister pack.
MSN-SOLIFENACIN solifenacin succinate 10 mg film-coated tablet blister pack (314024)

10 January 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-SOLIFENACIN solifenacin succinate 10 mg film-coated tablet blister pack.
Accelagen Pty Ltd - Severe acute respiratory syndrome-associated coronavirus IVDs Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Accelagen Pty Ltd
RESOLUTE 2.0

3 June 2021

COVID-19 test kit

Nucleic Acid Test - Intended for use: Laboratory.
Plunkett Consulting Pty Ltd - General/multiple surgical laser system beam guide Cancelled under Section 41GL(d) of the Act

19 April 2021

Cancellation by sponsor

Requested by Accelagen Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.